| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7K | +0.0% |
| Cost of Revenue | $5K | +0.0% |
| Gross Profit | $1K | +0.0% |
| R&D Expense | $47K | -57.5% |
| SG&A Expense | $273K | +511.1% |
| Operating Income | -$375K | +55.5% |
| Net Income | -$332K | +60.5% |
| EPS (Basic) | -$0.01 | +75.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28K | -76.6% |
| Inventory | $13K | +0.0% |
| Current Assets | $28K | -87.4% |
| Total Assets | $29K | -86.9% |
| Total Liabilities | $756K | -4.1% |
| Stockholders' Equity | -$727K | -28.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$139K | +52.9% |
| Capital Expenditures | $2K | +0.0% |
| Investing Cash Flow | $42K | +0.0% |
| Financing Cash Flow | $48K | -85.2% |
| Free Cash Flow | -$141K | +52.5% |